SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-045774
Filing Date
2023-12-21
Accepted
2023-12-21 17:56:07
Documents
1
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4048
  Complete submission text file 0001493152-23-045774.txt   5653
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Issuer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2301, 23RD FLOOR, TIFFANY TOWERS CLUSTER W, JLT, DUBAI, UAE DUBAI C0 4452
Business Address
Nanda Ashish (Reporting) CIK: 0001764445 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38416 | Film No.: 231506662